Challenges for HCV vaccine development in HIV-HCV coinfection (Q38036684)

27 August 2017

title

Challenges for HCV vaccine development in HIV-HCV coinfection (English)

1 reference

27 August 2017

5

Thomas F Baumert

1 reference

27 August 2017

2

Heidi Barth

1 reference

27 August 2017

Françoise Stoll-Keller

series ordinal

6

object named as

Françoise Stoll-Keller

1 reference

27 August 2017

7

Samira Fafi-Kremer

1 reference

27 August 2017

Mélanie Lambotin

1

1 reference

27 August 2017

Christiane Moog

series ordinal

3

1 reference

27 August 2017

François Habersetzer

series ordinal

4

1 reference

27 August 2017

publication date

1 July 2012

1 reference

Expert Review of Vaccines

27 August 2017

published in

1 reference

27 August 2017

volume

11

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

791-804

1 reference

Epidemiology of viral hepatitis and HIV co-infection

27 August 2017

cites work

1 reference

Coinfection with HIV-1 and HCV--a one-two punch

21 January 2018

1 reference

Antiviral strategies in hepatitis C virus infection

21 January 2018

1 reference

Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

The challenge of hepatitis C in the HIV-infected person

21 January 2018

1 reference

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009.

21 January 2018

1 reference

Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak?

21 January 2018

1 reference

Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission

21 January 2018

1 reference

Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study

21 January 2018

1 reference

Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection

21 January 2018

1 reference

Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis

21 January 2018

1 reference

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.

21 January 2018

1 reference

21 January 2018

1 reference

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control

21 January 2018

1 reference

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

21 January 2018

1 reference

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

21 January 2018

1 reference

Hepatitis C infection in HIV-1 natural viral suppressors.

21 January 2018

1 reference

Hepatitis C virus replication in Caucasian HIV controllers.

21 January 2018

1 reference

Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

21 January 2018

1 reference

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.

21 January 2018

1 reference

Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.

21 January 2018

1 reference

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

21 January 2018

1 reference

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

21 January 2018

1 reference

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

21 January 2018

1 reference

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy

21 January 2018

1 reference

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

21 January 2018

1 reference

Hepatitis C virus reinfection in injection drug users

21 January 2018

1 reference

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection

21 January 2018

1 reference

Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain

21 January 2018

1 reference

Hepatic T cells and liver tolerance

21 January 2018

1 reference

Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source

21 January 2018

1 reference

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study

21 January 2018

1 reference

Clearance of HCV RNA following acute hepatitis A superinfection

21 January 2018

1 reference

Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response

21 January 2018

1 reference

Clearance of chronic HCV infection during acute delta hepatitis.

21 January 2018

1 reference

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

21 January 2018

1 reference

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

21 January 2018

1 reference

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients

21 January 2018

1 reference

Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection

21 January 2018

1 reference

Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection.

21 January 2018

1 reference

Diminished frequency of hepatitis C virus specific interferon secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients

21 January 2018

1 reference

Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients

21 January 2018

1 reference

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

21 January 2018

1 reference

The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.

21 January 2018

1 reference

Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection

21 January 2018

1 reference

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy

21 January 2018

1 reference

A look behind closed doors: interaction of persistent viruses with dendritic cells

21 January 2018

1 reference

Three Dimensional Structure of the MqsR:MqsA Complex: A Novel TA Pair Comprised of a Toxin Homologous to RelE and an Antitoxin with Unique Properties

21 January 2018

1 reference

Chronic innate immune activation as a cause of HIV-1 immunopathogenesis

21 January 2018

1 reference

DCs and NK cells: critical effectors in the immune response to HIV-1.

21 January 2018

1 reference

Natural killer cells and hepatitis C: action and reaction

21 January 2018

1 reference

B cells in HIV infection and disease

21 January 2018

1 reference

HIV infection increases HCV-induced hepatocyte apoptosis

21 January 2018

1 reference

HIV increases HCV replication in a TGF-beta1-dependent manner.

21 January 2018

1 reference

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals.

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

21 January 2018

1 reference

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy

21 January 2018

1 reference

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

21 January 2018

1 reference

Human immunodeficiency virus and liver disease forum 2010: conference proceedings

21 January 2018

1 reference

Hepatitis C virus-human immunodeficiency virus coinfection

21 January 2018

1 reference

Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients

21 January 2018

1 reference

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

21 January 2018

1 reference

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

21 January 2018

1 reference

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

21 January 2018

1 reference

Vaccination of chimpanzees against infection by the hepatitis C virus

21 January 2018

1 reference

Prospects for a vaccine against the hepatitis C virus

21 January 2018

1 reference

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

21 January 2018

1 reference

Development of hepatitis C virus vaccines: challenges and progress.

21 January 2018

1 reference

Vaccination for hepatitis C virus: closing in on an evasive target

21 January 2018

1 reference

Progress in the development of preventive and therapeutic vaccines for hepatitis C virus

21 January 2018

1 reference

Hepatitis C vaccine: supply and demand

21 January 2018

1 reference

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

21 January 2018

1 reference

Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

21 January 2018

1 reference

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers

21 January 2018

1 reference

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques

21 January 2018

1 reference

A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.

21 January 2018

1 reference

Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.

21 January 2018

1 reference

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

21 January 2018

1 reference

The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation

21 January 2018

1 reference

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

21 January 2018

1 reference

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations

21 January 2018

1 reference

The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus

21 January 2018

1 reference

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

21 January 2018

1 reference

Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals

21 January 2018

1 reference

Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients

21 January 2018

1 reference

Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis

21 January 2018

1 reference

Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals

21 January 2018

1 reference

Pathogenic mechanisms of HIV disease

21 January 2018

1 reference

Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.

21 January 2018

1 reference

Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management

21 January 2018

1 reference

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

21 January 2018

1 reference

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

21 January 2018

1 reference

Systems biology of vaccination for seasonal influenza in humans

21 January 2018

1 reference

Systems vaccinology: its promise and challenge for HIV vaccine development

21 January 2018

1 reference

Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.52

1 reference

27 August 2017

1 reference